JP3982400008
JP3982400008
ROHTO PHARMACEUTICAL CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 343.725.000.000 | 308.625.000.000 | 11.4% |
| Cost of Revenue | 151.030.000.000 | 134.232.000.000 | 12.5% |
| Gross Profit | 192.695.000.000 | 174.393.000.000 | 10.5% |
| 151.573.000.000 | 136.154.000.000 | 11.3% | |
| Operating Income | 41.122.000.000 | 38.239.000.000 | 7.5% |
| Pretax Income | 46.821.000.000 | 41.626.000.000 | 12.5% |
| Net Income Common Stockholders | 34.247.000.000 | 30.841.000.000 | 11.0% |
| -- | -- | -- | |
| -- | -- | -- |